Ma Songjiang (CIK 1985547) reported 12 SEC Form 4 insider transactions across 1 companies over the past 18 months (most recent 2025-05-29). Recent activity: Sell GYRE (2,000 shares), Sell GYRE (558 shares), Sell GYRE (2,000 shares), Sell GYRE (182 shares), Sell GYRE (2,000 shares). Source: SEC Form 4.
| Date | Company | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2025-05-29 | GYRE THERAPEUTICS, INC. (GYRE) | President | Sell | 2,000 | $20,560 |
| 2025-05-29 | GYRE THERAPEUTICS, INC. (GYRE) | President | Sell | 558 | $5,619 |
| 2025-05-27 | GYRE THERAPEUTICS, INC. (GYRE) | President | Sell | 2,000 | $21,940 |
| 2025-05-27 | GYRE THERAPEUTICS, INC. (GYRE) | President | Sell | 182 | $1,864 |
| 2025-05-22 | GYRE THERAPEUTICS, INC. (GYRE) | President | Sell | 2,000 | $22,500 |
| 2025-05-22 | GYRE THERAPEUTICS, INC. (GYRE) | President | Sell | 2,000 | $21,660 |
| 2025-05-20 | GYRE THERAPEUTICS, INC. (GYRE) | President | Sell | 2,000 | $22,620 |
| 2025-05-20 | GYRE THERAPEUTICS, INC. (GYRE) | President | Sell | 2,000 | $22,220 |
| 2025-05-16 | GYRE THERAPEUTICS, INC. (GYRE) | President | Sell | 20 | $226 |
| 2025-05-16 | GYRE THERAPEUTICS, INC. (GYRE) | President | Sell | 2,000 | $21,360 |
| 2025-05-14 | GYRE THERAPEUTICS, INC. (GYRE) | President | Sell | 2,000 | $21,120 |
| 2025-05-14 | GYRE THERAPEUTICS, INC. (GYRE) | President | Sell | 2,000 | $22,740 |
Source: SEC Form 4 filings · as of 2025-05-29